Infection T Cells during Viral + Virus-Specific CD 4 Strategies of Human Brain-Infiltrating JC TCR Bias and HLA Cross-Restriction Are Eiermann

[1]  L. Jones,et al.  Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. , 2011, Brain : a journal of neurology.

[2]  L. Ngo,et al.  Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome , 2011, Journal of Virology.

[3]  D. Douek,et al.  Bias in the αβ T‐cell repertoire: implications for disease pathogenesis and vaccination , 2011, Immunology and cell biology.

[4]  K. Simon,et al.  Anti‐JC virus antibodies: Implications for PML Risk Stratification , 2010, Annals of neurology.

[5]  H. Urbach.  Comment to: Progressive Multifocal Leukoencephalopathy and Other Disorders Caused by JC Virus: Clinical Features and Pathogenesis , 2010, Clinical Neuroradiology.

[6]  I. Koralnik,et al.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis , 2010, The Lancet Neurology.

[7]  G. Pantaleo,et al.  Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study , 2010, The Lancet Neurology.

[8]  Andreas Radbruch,et al.  Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. , 2010, Immunity.

[9]  E. Major.  Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. , 2010, Annual review of medicine.

[10]  I. Koralnik,et al.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  J. McArthur,et al.  PML-IRIS in patients with HIV infection , 2009, Neurology.

[12]  Nitin J. Karandikar,et al.  Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. , 2008, Archives of neurology.

[13]  J. Bell,et al.  The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. , 2008, Immunity.

[14]  P. Doherty,et al.  Structural determinants of T-cell receptor bias in immunity , 2006, Nature Reviews Immunology.

[15]  I. Koralnik.  Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? , 2006, Annals of neurology.

[16]  N. Letvin,et al.  JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients , 2006, Journal of Neuroimmunology.

[17]  S. Cepok,et al.  Immune surveillance in multiple sclerosis patients treated with natalizumab , 2006, Annals of neurology.

[18]  S. Migueles,et al.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses , 2005, The Journal of experimental medicine.

[19]  M. Bonneville,et al.  Selection of T Cell Clones Expressing High-Affinity Public TCRs within Human Cytomegalovirus-Specific CD8 T Cell Responses1 , 2005, The Journal of Immunology.

[20]  Natalie A Borg,et al.  CTL Recognition of a Bulged Viral Peptide Involves Biased TCR Selection1 , 2005, The Journal of Immunology.

[21]  M. Kuroda,et al.  A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. , 2004, Brain : a journal of neurology.

[22]  David E. Anderson,et al.  Cross-Reactive TCR Responses to Self Antigens Presented by Different MHC Class II Molecules , 2004, The Journal of Immunology.

[23]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[24]  M. Kuroda,et al.  Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36 in Patients with Proven or Possible Progressive Multifocal Leukoencephalopathy , 2003, Journal of Virology.

[25]  Charles M. Rice,et al.  HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help , 2003, Science.

[26]  F. Hudecz,et al.  Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16‐kDa protein , 2003, Clinical and experimental immunology.

[27]  J. Delfraissy,et al.  Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy , 2003, AIDS.

[28]  Hao Shen,et al.  Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory , 2003, Science.

[29]  R. Ahmed,et al.  CD8 T Cells Remember with a Little Help , 2003, Science.

[30]  M. Bevan,et al.  Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help , 2003, Science.

[31]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[32]  B. Walker,et al.  Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection , 2002, Journal of Virology.

[33]  I. Koralnik.  Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. , 2002, Journal of neurovirology.

[34]  Arne Svejgaard,et al.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.

[35]  Christopher Garcia,et al.  Faculty Opinions recommendation of Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. , 2002 .

[36]  J. Schmitz,et al.  Association of Prolonged Survival in HLA-A2+ Progressive Multifocal Leukoencephalopathy Patients with a CTL Response Specific for a Commonly Recognized JC Virus Epitope1 , 2002, The Journal of Immunology.

[37]  C. Hallahan,et al.  High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Kappler,et al.  T Cell Receptor (Tcr)-Mediated Repertoire Selection and Loss of Tcr Vβ Diversity during the Initiation of a Cd4+ T Cell Response in Vivo , 2000, The Journal of experimental medicine.

[39]  E. Rosenberg,et al.  Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.

[40]  J. Currier,et al.  Invariant or highly conserved TCR alpha are expressed on double-negative (CD3+CD4-CD8-) and CD8+ T cells. , 1999, Journal of immunology.

[41]  J. Panus,et al.  Evolution of Antigen-specific T Cell Receptors In Vivo: Preimmune and Antigen-driven Selection of Preferred Complementarity-determining Region 3 (CDR3) Motifs , 1999, The Journal of experimental medicine.

[42]  T. Lybrand,et al.  Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. , 1998, Journal of immunology.

[43]  S. Rowland-Jones,et al.  Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific , 1998, The Journal of experimental medicine.

[44]  S. Turner,et al.  A dominant V beta bias in the CTL response after HSV-1 infection is determined by peptide residues predicted to also interact with the TCR beta-chain CDR3. , 1998, Molecular immunology.

[45]  R M Zinkernagel,et al.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Rammensee,et al.  The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized. , 1997, Human immunology.

[47]  J. Currier,et al.  Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. , 1996, Human immunology.

[48]  M. V. von Herrath,et al.  CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge , 1996, Journal of virology.

[49]  M. Davis,et al.  Antigen-specific development of primary and memory T cells in vivo. , 1995, Science.

[50]  J. Bell,et al.  Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment , 1995, The Journal of experimental medicine.

[51]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[52]  J. Cabaniols,et al.  Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice , 1994, The Journal of experimental medicine.

[53]  J. Bell,et al.  Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Rutherford,et al.  Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, san francisco, 1981–1989 , 1991, Annals of neurology.

[55]  C. Ryschkewitsch,et al.  JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Padgett,et al.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. , 1971, Lancet.

[57]  V. Puri,et al.  Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+T lymphocytopenia. , 2010, Neurology India.

[58]  J. Metcalf,et al.  Idiopathic CD4 (cid:1) lymphocytopenia: natural history and prognostic factors , 2008 .

[59]  J. Stockman.  Progressive Multifocal Leukoencephalopathy Complicating Treatment With Natalizumab and Interferon Beta-1a for Multiple Sclerosis , 2007 .

[60]  R. Simon,et al.  Haplotype Multiple Sclerosis-Associated HLA-DR 2 of the HLA-DR and-DQ Molecules in the Redundancy in Antigen-Presenting Function , 2006 .

[61]  A. Verma.  Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab , 2006 .

[62]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. , 1992, Nature.